옵션 체인은 다양한 행사가격과 만기일에 대한 IQVIA Hldgs의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 IQVIA Hldgs에 대한 시장 심리를 평가합니다..

IQVIA Hldgs (NYSE:IQV) 주식, 옵션 체인

IQVIA Hldgs

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings

Analyst Color

Long Ideas

Health Care

Analyst Ratings

Tech

Trading Ideas

General

ILMN

NVDA

엔비디아(NASDAQ:NVDA)의 제품은 GPU와 게임에 국한되지 않는다. 이 기술 회사는 현재 헬스케어 인공지능 분야에서도 주목받고 있다. 월요일에 열린 J.P. 모건의 헬스케어 컨퍼런스에서 애널리스트 할란 서(Harlan Sur)는 엔비디아의 전략적 위치와 향후 성장의 주요 동력을 강조했다. 이것이 월스트리트와 병원들이 주목하고 있는 이유이다.

엔비디아가 의료 AI로 10억 달러의 매출을 겨냥: 다음 성장의 지평으로 거듭날까?

News

BILL

ETSY

ICLR

MTCH

SDRL

엘리엇 인베스트먼트 매니지먼트(Elliott Investment Management)는 3분기에 분주했다. 미 증권거래위원회(SEC)에 새로 제출한 13-F에 따르면 이 행동주의 투자자는 여행 및 숙박에 초점을 맞춘 여러 가지 새로운 포지션을 포함하여 여러 가지 포트폴리오 전환을 수행했다.

엘리엇이 3분기에 웨스턴 디지털, 엣시는 추가; 씨드릴, 블랙라인, NRG 에너지는 축소

IQVIA Holdings Inc

As a result, the Company achieved its improved full-year 2024 production guidance range of 130,000 to 140,000 ounces, representing a 19% beat to the mid-point of its initial production 2024 guidance of 110,000 to 120,000 ounces. As a result of this increased production the Company anticipates full year 2024 all-in sustaining cost1 (AISC) to be at the low end of the improved guidance range of $800 to $900 per ounce of gold sold. Complete financial and operating results for the fourth quarter and full year 2024 are expected to be provided on March 18, 2025.
&nbsp;
2025 Guidance Summary (Preliminary)
This preliminary guidance does not reflect the benefits of the Company's acquisition of the Musselwhite Mine from Newmont Corporation, announced on November 18, 2024, which is anticipated to close in the first quarter of 2025. Updated 2025 guidance, including the Musselwhite Mine and corporate G&amp;A will be provided following the transaction's closing. The Company's preliminary 2025 guidance is set forth below.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Gold Production – Camino Rojo</td>
<td colspan="1" rowspan="1">oz</td>
<td colspan="1" rowspan="1">110,000 – 120,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Cash Cost (net of by-product) – Camino Rojo</td>
<td colspan="1" rowspan="1">$/oz sold</td>
<td colspan="1" rowspan="1">$625 – $725&nbsp;&nbsp;&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">AISC1&nbsp; – Camino Rojo</td>
<td colspan="1" rowspan="1">$/oz sold</td>
<td colspan="1" rowspan="1">$875 – $975</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$27.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Sustaining capital expenditures – Camino Rojo</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$10.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Non-sustaining – capitalized exploration – Camino Rojo</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$7.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Non-sustaining – capital projects – South Carlin Complex</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$10.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Exploration and Project Development Expenses</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$36.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Regional Exploration – Camino Rojo</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$9.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Regional Exploration – South Carlin Complex</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$15.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;&nbsp;&nbsp; Project Development – South Carlin Complex</td>
<td colspan="1" rowspan="1">$m</td>
<td colspan="1" rowspan="1">$12.0</td>
</tr>
</tbody>
</table>
</figure>

Earnings

Guidance

Commodities

Markets

ORLA

Orla Mining Produced 26,531 Ounces Of Gold In The Fourth Quarter, Bringing Total Annual Gold Production For 2024 To 136,748 Ounces

A former OpenAI engineer&#8217;s death has sparked controversy after his mother claimed he possessed sensitive documents about the artificial intelligence company&#8217;s practices. Suchir Balaji, who had worked with Sam Altman&#8216;s AI company, was found dead in his San Francisco apartment in <a href="https://www.benzinga.com/media/24/12/42495291/openai-whistleblower-found-dead-after-raising-ai-copyright-concerns">what authorities ruled a suicide</a>.
What Happened: In an interview with Tucker Carlson on Thursday, Balaji&#8217;s mother, Poornima Ramarao, alleged her son was killed because of his knowledge about OpenAI&#8217;s operations. 
&#8220;New York Times named my son as a custodian witness&#8230; He had documents against OpenAI,&#8221; Ramarao stated, adding that Balaji had recently returned from a vacation in Los Angeles before his death.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
The case has drawn attention from Tesla Inc. CEO Elon Musk, a former OpenAI co-founder, who described the situation as &#8220;extremely concerning&#8221; on social media. Musk had previously expressed skepticism about the suicide ruling.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Extremely concerning <a href="https://t.co/ze1mmlIMdD">pic.twitter.com/ze1mmlIMdD</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1879795436623630825?ref_src=twsrc%5Etfw">January 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
According to Ramarao, Balaji had opposed OpenAI&#8217;s shift toward a profit-driven model and had raised concerns about the company&#8217;s copyright practices, particularly regarding its fair use defense for generative AI. 
See Also: <a href="https://www.benzinga.com/news/25/01/43019094/bidens-farewell-address-targets-tech-oligarchy-in-trump-2-0-era-president-says-americans-face-avalanche-of-misinformation">Biden&#8217;s Farewell Address Targets Tech Oligarchy In Trump 2.0 Era: President Says Americans Face &#8216;Avalanche Of Misinformation&#8217;</a>
Why It Matters: She emphasized that her son&#8217;s knowledge extended beyond copyright issues, stating he had unique insights into the company&#8217;s pre-training data processes.
&#8220;This is not just about copyright—it involves much more, including matters that could potentially harm society. This isn't just about my son's death. There are harmful practices that need to be evaluated and thoroughly investigated,&#8221; Ramarao said. 
The family is seeking to become estate administrators to access sealed documents held by The New York Times. Ramarao has called for a federal investigation, questioning why medical examiners have allegedly refused to meet with the family.
The controversy emerges amid growing scrutiny of AI development and its oversight. Balaji&#8217;s role as a custodian witness and his alleged possession of internal documents add significance to the case, particularly as debates continue about AI companies&#8217; practices and transparency.
OpenAI did not immediately respond to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment. The San Francisco Police Department maintains its initial suicide ruling.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/43021419/palantirs-shyam-sankar-says-spacex-and-tesla-are-models-for-reviving-american-manufacturing-amid-rising-concerns-over-military-readiness">Palantir&#8217;s Shyam Sankar Says SpaceX And Tesla Are Models For Reviving American Manufacturing Amid Rising Concerns Over Military Readiness</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

OpenAI Whistleblower Suchir Balaji's Mother Says Her Son Had Documents Against Sam Altman's AI Startup: Elon Musk Calls It 'Extremely Concerning'

MNTS

Momentus Granted Nasdaq Listing Extension Until April 15, 2025, To Regain Compliance With Listing Rule 5550(b)

<ul>
<li>ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks</li>
<li>BLA resubmission on track for calendar Q1 2025</li>
<li>Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceeds</li>
</ul>

Biotech

OTLK

Outlook Therapeutics Completed The Analysis Of The Complete 12-Week Safety And Efficacy Results For NORSE EIGHT Trial Of ONS-5010 In Wet Age-related Macular Degeneration Patients, Demonstrating Noninferiority To Ranibizumab, Plans To Resubmit The Biologics License Application In Q1 Of Calendar 2025.

PicoCELA intends to use the net proceeds from the Offering for (i) working capital for inventory production, (ii) product and service improvement, and (iii) research and development for new product and services.
 &nbsp;

IPOs

PCLA

Tokyo-Based PicoCELA Prices IPO Of 1.75M American Depositary Shares At $4.00 Per ADS; To Begin Trading On Nasdaq Under Ticker Symbol 'PCLA'

Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) disclosed that it expects global total shipments to decline 9% year-over-year to around 1.395 million units <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43020587/stellantis-reports-q4-2024-consolidated-shipment-estimates" rel="noreferrer noopener">for the fourth quarter of 2024</a>.
The decrease aligned with a ~5% drop in underlying&nbsp;sales performance. The company&#8217;s 9%&nbsp;decline in shipments improved versus a 20%&nbsp;decline in the third quarter, as U.S. inventory reduction actions concluded and new product launches in Europe reduced gaps in its offering related to generational portfolio transition.
In North America, shipments fell by 28%, while sales dropped 5% Y/Y. The sharper shipment decline was due to inventory reduction efforts, cutting U.S. dealer stock by ~80,000 units to just over 300,000 by quarter-end.
In Enlarged Europe, shipments fell 6% Y/Y, an improvement from the third-quarter decline of 17% Y/Y, thanks to the Citroën C3/ë-C3 launch helping close a temporary B-segment gap.
The company stated that early demand for Stellantis&#8217; next-generation models is strong, with over 90,000 orders for the Citroën C3/ë-C3 and more than 140,000 for STLA Medium platform models, including the Peugeot 3008, Peugeot 5008, and Opel Grandland.
Apart from this, Stellantis&#8217; &#8220;Third Engine&#8221; shipments rose 5% Y/Y, led by 12% growth in South America and stability in the Middle East &amp; Africa, offsetting declines in China and India &amp; Asia Pacific.
South America benefited from stronger demand and a post-flood production rebound, while Middle East &amp; Africa saw gains in key markets, tempered by import restrictions in Algeria.
The company plans to report FY24 results <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">on February 26, 2025</a>.
Last week, the company inked a non-binding Memorandum of Understanding to accelerate the cloud-based <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42844621/stellantis-partners-with-dspace-to-accelerate-cloud-based-development-of-vehicles" rel="noreferrer noopener">development of Stellantis vehicles</a>.
Price Action: STLA shares are up 0.16% at $12.77 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42882959/intel-partners-with-amazon-cloud-to-drive-next-gen-smart-vehicle-tech" target="_blank" rel="noreferrer noopener">Intel Partners with Amazon Cloud to Drive Next-Gen Smart Vehicle Tech, Wins Stellantis, Karma Auto As Clients</a></li>
</ul>
Photo by Jonathan Weiss on Shutterstock.

Equities

Large Cap

STLA

Stellantis Projects 9% Shipment Decline For Q4 Amid US Inventory Cuts

UnitedHealth Group Affirms 2025 Outlook With Sales Of $450B-$455B And Adjusted EPS Of $29.50-$30.00 Compared To Consensus Of $448.125B And $29.83, Respectively And Cash Flow From Operations Of $32B-$33B

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported quarterly earnings of $6.81 per share which beat the analyst consensus estimate of $6.72 by 1.34 percent. The company reported quarterly sales of $100.81 billion which missed the analyst consensus estimate of $101.76 billion by 0.94 percent. This is a 6.76 percent increase over sales of $94.43 billion the same period last year.

UnitedHealth Group Q4 2024 Adj EPS $6.81 Beats $6.72 Estimate, Sales $100.81B Miss $101.76B Estimate

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Krispy Kreme Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>)</h3>
<ul>
<li>On Jan. 9, Krispy Kreme announced changes to its global leadership team, naming Nicola Steele as incoming COO. &#8220;These leaders all have extensive company experience, commitment to operational excellence and passion for our iconic fresh doughnuts and beloved brand,&#8221; said Josh Charlesworth, Krispy Kreme CEO. &#8220;As we grow, these leadership changes will result in both a bigger and better Krispy Kreme.&#8221; The company' stock fell around 7% over the past mfive daysonth and has a <a href="https://www.benzinga.com/quote/DNUT">52-week low of $8.78</a>.</li>
<li>RSI Value: 27.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>DNUT Price Action: Shares of Krispy Kreme fell 0.6% to close at $8.94 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1">DNUT news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="807" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054417/image-103.png" alt="" class="wp-image-736405" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054417/image-103.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054417/image-103-300x267.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054417/image-103-768x683.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Wendy&#8217;s Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>The Wendy&#8217;s Company will report fourth quarter and full year 2024 results on Feb. 13, 2025. The company's stock fell around 10% over the past month and <a href="https://www.benzinga.com/quote/WEN">has a 52-week low</a> of $14.74.</li>
<li>RSI Value: 23.9</li>
<li>WEN Price Action: Shares of Wendy&#8217;s closed at $15.13 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1">in WEN stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="918" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054512/image-104.png" alt="" class="wp-image-736406" style="width:595px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054512/image-104.png 918w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054512/image-104-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054512/image-104-768x704.png 768w" sizes="(max-width: 918px) 100vw, 918px" /></a></figure>
<h3 class="wp-block-heading">Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>)</h3>
<ul>
<li>On Jan. 14, Morgan Stanley downgraded the stock from Overweight to Equal-Weight and cut its price target from $53 to $51. The company's stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/LVS">low of $36.62</a>.</li>
<li>RSI Value: 23.5</li>
<li>LVS Price Action: Shares of Las Vegas Sands fell 1.8% to close at $44.20 on Wednesday. </li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1">breakout in LVS shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="890" height="848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054605/image-105.png" alt="" class="wp-image-736409" style="width:541px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054605/image-105.png 890w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054605/image-105-300x286.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16054605/image-105-768x732.png 768w" sizes="(max-width: 890px) 100vw, 890px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

DNUT

Top 3 Consumer Stocks You'll Regret Missing This Month

CNBC&#8217;s Jim Cramer took to the social media platform X to endorse Taiwan Semiconductor Manufacturing Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) strong fourth-quarter <a href="https://www.benzinga.com/25/01/43019420/quantum-computing-taiwan-semiconductor-meta-intuitive-surgical-and-tesla-why-these-5-stocks-are-on-investors-radars-today">earnings</a> while taking a jibe at outgoing president Joe Biden&#8216;s sanctions on the chipmaker.
What Happened: Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chip supplier TSMC beat its fourth-quarter revenue and earnings per share estimates on Thursday, &#8220;telling an excellent story,&#8221; according to Cramer&#8217;s X post.
However, Cramer added flavor to his observation by stating &#8220;what semi-sanction will Biden pull out of the hat next!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Taiwan Semi telling an excellent story that is good for NVDA, too, but what semi-sanction will Biden pull out of the hat next!!!
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1879779490894880972?ref_src=twsrc%5Etfw">January 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
TSMC delivered earnings of $2.24 per share on revenue of $26.88 billion. The EPS was 3.70% higher, whereas the revenue was 1.91% higher as compared to estimates.
The earnings also beat revenue guidance of $25.8 billion, whereas the gross margin for the quarter was in line with 59% growth guided by the company.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42999475/amd-shares-hint-at-a-reversal-as-charts-show-bullish-stick-sandwich-following-a-double-downgrade-from-hsbc">AMD Shares Hint At A Reversal As Charts Show Bullish Stick Sandwich Following A Double Downgrade From HSBC</a> 
Why It Matters: On Wednesday, the Biden administration placed over two dozen Chinese entities on a U.S. trade restriction list, including Zhipu AI, a developer of large language models, and Sophgo, a company whose TSMC-manufactured chip was unlawfully integrated into a Huawei AI processor, reported Reuters.
Additionally, the Commerce Department enhanced controls on chip exports to China to more effectively prevent diversion to Huawei.
Price Action: TSMC&#8217;s stock was up 3.14% in premarket to $213.44 on Thursday. Over the past year, it has experienced a notable growth of 103.40%.
TSMC has a consensus price target of $200.8, according to the 6 analysts <a href="https://www.benzinga.com/quote/TSM/analyst-ratings">tracked by Benzinga</a>. The high target is $250, and the low is $89. Recent ratings by Barclays, Barclays, and Needham suggest a $226.67 target, implying a 4.67% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/TSM/analyst-ratings"><img loading="lazy" decoding="async" width="945" height="355" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16044358/TSMC-ANR.png" alt="" class="wp-image-736272" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16044358/TSMC-ANR.png 945w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16044358/TSMC-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16044358/TSMC-ANR-768x289.png 768w" sizes="(max-width: 945px) 100vw, 945px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43021065/cash-app-parent-block-inc-eyes-395-upside-bofa-believes-us-centric-re-acceleration-story-will-drive-the-stock">Jack Dorsey&#8217;s Block Eyes Over 39% Upside: BofA Says US-Centric Re-Acceleration Story Will Drive The Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Jim Cramer Quips About Joe Biden's TSMC Chips Sanction As Nvidia Supplier Beats Q4 Estimates

Guidance for FY25: &nbsp;• Revenue growth of 4.5%-5.0% in constant currency • Operating margin of 20%-22%&nbsp;

INFY

Infosys Expects FY25 Revenue Growth of 4.5%-5.0% (Prior 3.75%-4.50%) in Constant Currency, Reiterated Operating Margin of 20%-22%

The Cyberpunk 2077 hub is free to all Opera GX users. Accessible from the GX Corner home page, the hub brings a range of game-focused features.

OPRA

Opera Unveils Opera GX hub, A New Feature Designed To Blend Favorite Games Directly Into The Browser

<ul>
<li>M&amp;T's capital position continues to strengthen as the CET1 capital ratio increased for the seventh consecutive quarter to an estimated 11.67% at December 31, 2024, representing a 13 basis-point increase from 11.54% at September 30, 2024. M&amp;T repurchased shares of its common stock for a total cost of $200 million, including the share repurchase excise tax, in the fourth quarter of 2024.</li>
</ul>

M&T's CET1 Capital Ratio Rose For The Seventh Straight Quarter To 11.67% As Of December 31, 2024, Up 13 Basis Points From September

On Thursday, Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) fourth-quarter results beat forecasts, fueled by demand for advanced processor node technologies for artificial intelligence applications.
The contract chipmaker, which supplies chips for&nbsp;Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) graphics processing unit&nbsp;(GPU)&nbsp;and Apple, Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) smartphones, guided first-quarter revenue <a target="_blank" href="https://investor.tsmc.com/english/quarterly-results/2024/q4" rel="noreferrer noopener">above the consensus</a>.
Taiwan Semiconductor reported fourth-quarter revenue of $26.88 billion (NT$868.46 billion), up 38.8% year-over-year, topping the analyst consensus estimate of $26.28 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43013634/opecs-optimism-clashes-with-ieas-conservative-2025-oil-growth-projections" rel="noreferrer noopener">OPEC&#8217;s Optimism Clashes With IEA&#8217;s Conservative 2025 Oil Growth Projections</a>
Net income and earnings per share were NT$374.68 billion and NT$14.45 per share ($2.24) versus <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus of $2.23</a>.
In dollar terms, revenue growth was 37.0% year over year and 14.4% quarter over quarter. <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41373163/nvidia-supplier-tsmc-reports-q3-revenue-earnings-beat-amid-rising-demand-for-ai-chips" rel="noreferrer noopener">The top-line performance</a> aligned with the company&#8217;s guidance of $26.1 billion—$26.9 billion.
Taiwan Semiconductor said its business was supported by demand for its 3-nm and 5-nm technologies. However, it expects smartphone seasonality to impact the first quarter, partially offset by continued growth in AI-related demand.
The company said 3-nm accounted for 26% of the total revenue, 5-nm accounted for 34%, and 7-nm technologies accounted for 14%. 7-nm and more advanced technologies comprised 74% of the total wafer revenue.
Margin Profile:&nbsp;Taiwan Semiconductor&#8217;s AI technology moat helped it expand its fourth-quarter gross margins by 600 bps to 59%, as its 3-nm and 5-nm chips gain traction at the cost of&nbsp;Intel Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and&nbsp;Samsung Electronics&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>),&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/42825523/taiwan-semi-likely-for-upside-backed-by-ai-demand-and-advanced-node-pricing-analyst-says" rel="noreferrer noopener">which struggled to transition</a>&nbsp;into advanced nodes. Taiwan Semiconductor&#8217;s operating margin expanded by 740 bps to 49%.
Outlook: Taiwan Semiconductor is guided for first-quarter 2025 revenue of $25.0 billion-$25.8 billion versus the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$24.97 billion consensus estimate</a>. It expects a gross margin of 57%—59% and operating profit margins of 46.5%—48.5%.
The company earmarked fiscal 2025 capex worth $38 billion-$42 billion (versus $29.8 billion a year ago) amid intensifying geopolitical tensions between the U.S. and China, with the former eying tougher <a target="_blank" href="https://www.benzinga.com/25/01/43003008/taiwan-semi-samsung-intel-may-face-stricter-us-rules-on-chip-exports-to-china-over-security-concerns" rel="noreferrer noopener">artificial intelligence technology</a> restrictions on the latter, citing national security concerns.
Taiwan Semiconductor stock surged over 103% in the last 12 months.
Investors can gain exposure to semiconductor manufacturing stocks through the VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) and the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>).
Price Action: TSM stock traded higher by 4.86% at $216.85 premarket at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43008511/broadcoms-latest-san-switch-offers-scalable-energy-efficient-solution-for-growing-storage-demands" target="_blank" rel="noreferrer noopener">Broadcom&#8217;s Latest SAN Switch Offers Scalable, Energy-Efficient Solution for Growing Storage Demands</a></li>
</ul>
Photo by wakamatsu.h via Shutterstock

Movers

AAPL

INTC

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SSNLF

Taiwan Semiconductor Q4 Earnings: 3nm and 5nm Nodes Lead Topline Growth, Expands Margins, Issues Strong Q1 Outlook

Earnings Beats

Infosys Q3 2025 GAAP EPS $0.19, Inline, Sales $4.939B Beat $4.882B Estimate

M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) reported quarterly earnings of $3.92 per share which beat the analyst consensus estimate of $3.73 by 5.09 percent. This is a 39.5 percent increase over earnings of $2.81 per share from the same period last year. The company reported quarterly sales of $2.385 billion which beat the analyst consensus estimate of $2.340 billion by 1.93 percent. This is a 3.70 percent increase over sales of $2.300 billion the same period last year.

M&T Bank Q4 2024 Adj. EPS $3.92 Beats $3.73 Estimate, Sales $2.385B Beat $2.340B Estimate

STGW

Stagwell Announces Intent To Acquire ADK GLOBAL, Strengthening APAC Presence And Expanding Global Marketing Reach With Local Market Expertise

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) on Wednesday launched 365 Copilot Chat, its AI-powered chat service with AI agents and a new pay-as-you-go plan.
What Happened: The company has rebranded its AI chat service, formerly known as Bing Chat Enterprise, under a new plan named Microsoft 365 Copilot Chat.
The service is tailored for businesses and offers features centered on workflow automation.
The Copilot Chat is built on OpenAI&#8217;s GPT-4 AI model and can be used for tasks such as conducting market research, preparing for meetings, creating key takeaways in Word documents, and even generating AI-powered images for social media posts and campaigns using Copilot Pages.
See Also: <a href="https://www.benzinga.com/25/01/43019833/elon-musk-buying-tiktok-could-hurt-tesla-warns-gary-black-but-dan-ives-thinks-it-makes-sense">Elon Musk Buying TikTok Could Hurt Tesla Stock, Warns Gary Black — But Wedbush's Dan Ives Thinks It Makes Sense</a>
Earlier, AI agents were only accessible with the full Microsoft Copilot subscription, which costs $30 per user per month. However, with the new Copilot Chat plan, businesses can access Copilot AI agents directly within the chat experience and pay based on usage.
While the exact cost for Copilot Chat will vary depending on usage, it&#8217;s a significant move towards flexible pricing, particularly beneficial for businesses with fluctuating needs or smaller teams that may not require constant access to AI agents.
Copilot Chat is available in the Microsoft 365 Copilot app for Windows, Android, or iPhone app stores or via Microsoft 365 Copilot&#8217;s official website.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Announcing Microsoft 365 Copilot Chat. Making AI more accessible to every employee in every business. <a href="https://t.co/cHD89JuxHz">pic.twitter.com/cHD89JuxHz</a>
&mdash; Satya Nadella (@satyanadella) <a href="https://twitter.com/satyanadella/status/1879530451716776062?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: The introduction of AI agents in Microsoft 365 Copilot Chat is part of a broader trend in the tech industry towards integrating AI into everyday business operations.
Startups like OpenAI or established players like Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google have already rolled out or are <a href="https://www.benzinga.com/24/12/42446686/google-introduces-ai-agent-prototype-that-can-browse-the-web">preparing to introduce</a> comparable AI agent tools.
Meta Platforms Inc. (META) CEO Mark Zuckerberg has also addressed the transition from chatbots to AI agents capable of handling more complex tasks and goals.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang has likewise forecasted that AI-powered employees will soon become a <a href="https://www.benzinga.com/tech/24/11/41869577/nvidias-huang-sees-ai-employees-on-the-horizon">vital component of the corporate</a> workforce.
Moreover, Microsoft also faces mounting pressure to deliver returns on its significant AI investments, with the software giant planning to allocate <a href="https://www.benzinga.com/25/01/42801720/microsoft-to-invest-80-billion-in-ai-data-centers-for-fiscal-2025">about $80 billion this fiscal</a> year toward data centers and AI infrastructure.
In November last year, Microsoft started enabling customers to develop autonomous agents that need little human involvement. Some analysts suggest that this approach could provide tech companies with an easier route to monetization, noted Reuters.
Price Action: Microsoft&#8217;s stock increased by 2.56% on Wednesday, finishing at $426.31. In pre-market trading on Friday, it gained another 0.74%, reaching $429.48, as per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/01/42900737/stephen-king-slams-elon-musks-h-1b-visa-stance-musk-thinks-smart-immigrants-can-stay-the-rest-of-you-washing-dishes-get-lost">Stephen King Slams Elon Musk&#8217;s H-1B Visa Stance: ‘Musk Thinks Smart Immigrants Can Stay – The Rest of You Washing Dishes … Get Lost&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

GOOG

GOOGL

MSFT

Microsoft Launches 365 Copilot Chat For Business With Pay-As-You-Go Plan

HUIZ

Huize Launches "PrimeMed" Customized Mid-Tier Medical Insurance In Partnership With CCIC And MSH CHINA To Provide Access To High-Cost, Specialized Medical Resources

Macro Economic Events

Econ #s

Economics

Eurozone Trade Balance For November 16.4B Vs. 11.8B Est.; 6.8B Prior

Tracking William Nygren's Harris Associates Portfolio - Q3 2024 Update

Fortrea: Turning Around As The Activists Move In

RBC Capital analyst Sean Dodge maintained a Buy rating on IQVIA Holdings (IQV – Research Report) on January 8 and set a price target of $270.00. Th...

RBC Capital Sticks to Their Buy Rating for IQVIA Holdings (IQV)

Iqvia (IQV) is working with Nvidia (NVDA) to build "custom foundation models and agentic AI workflows that can accelerate research, clinical develo...

Iqvia working with Nvidia to build custom models, agentic AI workflows

NVIDIA (NVDA) today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, ...

Nvidia enters partnerships in healthcare, life sciences industry

Nvidia partnerships with Illumina, IQVIA use generative AI to boost drug discovery

Nvidia partners with Illumina, IQVIA use generative AI to boost drug discovery

Nvidia ($NVDA) is growing its presence in the healthcare sector with new partnerships, such as with gene sequencing company Illumina ($ILMN), among...

Nvidia (NVDA) Expands Healthcare Presence with Illumina Partnership

Investors should look into pockets of opportunities in global equities – Harris Associates

Oakmark Select Fund Q4 2024 Commentary

ABNB

ALLY

AMZN

BAYZF

CBRE

CHTR

CMCSA

CRBG

CSCO

CTVA

FCNCA

FTRE

KVUE

MBGAF

NDAQ

PAYC

PHIN

PPRUF

RYAAY

SCHW

WDAY

Press Releases

How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024

Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative

IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award

IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™

IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024

IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

AVAI

EXAI

RXRX

TWST

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

IQVIA Hldgs

IQVIA Hldgs (IQV) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌